Decreased cyclic AMP in the epidermis of lesions of psoriasis.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Archives of Dermatology

• Publication date

  1972-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.1972.01620080025008PMID 4337376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dibutyryl cyclic AMP inhibition of epidermal cell division.

  1972cited by this paper
• Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?

  1971cited by this paper
• Regulation of Adenosine 3′,5′-Cyclic Monophosphate Metabolism in Cultured Neuroblastoma Cells

  1971cited by this paper
• Beta adrenergic stimulation of endogenous epidermal cyclic AMP formation.

  1971cited by this paper
• Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives.

  1971cited by this paper
• Further changes in differentiation state accompanying the conversion of Chinese hamster cells of fibroblastic form by dibutyryl adenosine cyclic 3':5'-monophosphate and hormones.

  1971cited by this paper
• Morphologic differentiation of mouse neuroblastoma cells induced in vitro by dibutyryl adenosine 3':5'-cyclic monophosphate.

  1971cited by this paper
• METHODS OF ASSAY OF CYCLIC NUCLEOTIDES

  1971cited by this paper
• CHAPTER 5 – Some Actions of Cyclic AMP

  1971cited by this paper
• Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3':5'-cyclic monophosphate.

  1971cited by this paper
• Inhibition of replication in functional mouse adrenal tumor cells by adrenocorticotropic hormone mediated by adenosine 3':5'-cyclic monophosphate.

  1971cited by this paper
• Adenosine 3',5'-cyclic monophosphate and contact inhibition.

  1971cited by this paper
• Cyclic AMP levels in fibroblasts: relationship to growth rate and contact inhibition of growth.

  1971cited by this paper
• Isoproterenol-sensitive adenyl cyclase in a particulate fraction of epidermis.

  1971cited by this paper
• Analysis of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate.

  1971cited by this paper
• Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivatives.

  1971cited by this paper
• A method for bioassay of an epidermal chalone-like inhibitor.

  1971cited by this paper
• Cyclic adenosine monophosphate as a mediator of hormone action.

  1971cited by this paper
• Aggregation and differentiation in the cellular slime molds.

  1971cited by this paper
• A protein binding assay for adenosine 3':5'-cyclic monophosphate.

  1970cited by this paper
• EPIDERMAL REGENERATION AFTER CELLOPHANE TAPE STRIPPING OF HAIRLESS MOUSE SKIN

  1970cited by this paper
• Cyclic AMP.

  1968cited by this paper
• Abnormal cell proliferation in psoriasis.

  1968cited by this paper
• [105] Determination of DNA concentration with diphenylamine

  1968cited by this paper
• The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

  1968cited by this paper
• Metabolically active skin slices. Further improvement in the dissection of metabolically active uniformly thin skin slices.

  1967cited by this paper
• Carbohydrate metabolism in psoriasis: an enzymatic study.

  1966cited by this paper
• CHAPTER XXIV – Carbohydrate Metabolism in the Skin1

  1964cited by this paper
• Histopathology of the Skin

  1962cited by this paper
• Glycogen response in human epidermal basal cell.

  1962cited by this paper
• Observations on Glycogen in Epithelial Tumors1

  1958cited by this paper
• Observations on glycogen in epithelial tumors.

  1958cited by this paper
• THE HISTOCHEMISTRY OF PSORIASIS

  1958cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• CYCLIC ADENOSINE MONOPHOSPHATE, ADENYL CYCLASE AND CYCLIC NUCLEOTJDE PllOSPHODIESTERASE IN PSORIATJC EPIDERMIS With a Comment on Urinary cAMP

  2022cites this paper
• Assessing Antipsoriatic Effects of Bitter Pu’er Tea and Its Three Major Compounds, Strictinin, Theacrine and Epigallocatechin Gallate, in Imiquimod-Treated Mice

  2022cites this paper
• Beta2-adrenergic receptor agonist inhibits keratinocyte proliferation by mechanisms involving nitric oxide

  2020cites this paper
• Caffeine in the Treatment of Atopic Dermatitis and Psoriasis: A Review

  2019cites this paper
• Cyclic Adenosine Monophosphate Signaling in Inflammatory Skin Disease

  2015cites this paper
• HL-A antigens and some immunological parameters in psoriasis.

  2008cites this paper
• Beta adrenergic receptors in keratinocytes.

  2007cites this paper
• Phorbol-12-myristate-13-acetate Effect on Cyclic Adenosine 3',5'-Monophosphate Levels in Mouse Skin and Inhibition of Phorbol-myristate-acetate-promoted Tumorigenesis by Theophylline'

  2006cites this paper
• Influence of intercellular agents on proliferation and gene activity of cultured human skin epithelium cells (NCTC 2544)

  2004cites this paper
• β-adrenerge stimulation membrangebundener adenylcyklase in normaler epidermis und mangelnde stimulierbarkeit bei psoriasis

  2004cites this paper
• Verteilungsstörung oberflächlicher glycoconjugate der psoriatischen zellmembran

  2004cites this paper
• Interleukin-6 in psoriasis: expression and mitogenicity studies

  2004influential citation
• A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.

  2002cites this paper
• Metalloproteinases Stimulate ErbB-dependent ERK Signaling in Human Skin Organ Culture*

  2002cites this paper
• INTERFERENTIAL ELECTRIC FIELD TREATMENT REVEALED A LOW INCREASE OF SPONTANEOUS CARDIAC DIFFERENTIATION BUT NO CYCLIC AMP CHANGES NOR INDUCTION OF CARDIAC-SPECIFIC GENE EXPRESSION IN PLURIPOTENT EMBRYONAL CARCINOMA P19 CELLS

  2002cites this paper
• Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

  2001cites this paper
• EGF stimulates transcription of CaN19 (S100A2) in HaCaT keratinocytes.

  1998cites this paper
• Retinoid regulation of heparin‐binding EGF‐like growth factor gene expression in human keratinocytes and skin *

  1998cites this paper
• Immunopathogenesis of Psoriasis: News in an Old Concept

  1998cites this paper
• The therapeutic effects of vitamin D3 and its analogues in psoriasis.

  1998cites this paper
• Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.

  1997cites this paper
• Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.

  1997cites this paper
• Signal transduction pathways in epidermal proliferation and cutaneous inflammation.

  1995cites this paper
• Endogenous Retinoic Acid Receptor (RAR)-Retinoid X Receptor (RXR) Heterodimers Are the Major Functional Forms Regulating Retinoid-responsive Elements in Adult Human Keratinocytes

  1995cites this paper
• Retinoic acid induces expression of PA‐FABP (psoriasis‐associated fatty acid‐binding protein) gene in human skin in vivo but not in cultured skin cells

  1994cites this paper
• cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts.

  1993cites this paper
• Retinoic acid receptors and binding proteins in human skin.

  1992cites this paper
• [Psoriasis and beta-blockade].

  1992cites this paper
• Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin.

  1992cites this paper
• Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-gamma 1 in retinoic acid-treated human skin.

  1992cites this paper
• Differential regulation of retinoic acid receptors and binding proteins in human skin.

  1992cites this paper
• C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis.

  1991cites this paper
• Retinoic acid receptor gene expression in human skin.

  1991cites this paper
• Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro.

  1991cites this paper
• Beta‐adrenergic stimulation of cyclic AMP is defective in cultured dermal fibroblasts of psoriatic subjects

  1990cites this paper
• Protooncogene expression in normal and psoriatic skin.

  1990cites this paper
• Determination of cyclic AMP and cyclic GMP in psoriatic epidermis and dermis.

  1987cites this paper
• Effect of Dead-Sea brine and its main salts on cell growth in culture.

  1987cites this paper
• Surgical treatment of psoriasis: a review including a case report of dermabrasion of hypertrophic psoriatic plaques.

  1987cites this paper
• Unerwünschte Wirkungen der Lithiumtherapie an der Haut

  1986cites this paper
• The Development of Epidermis In Vitro. Electronmicroscopic and Autoradiographic Studies in the Limb Bud Culture

  1986cites this paper
• "Ischemic" rise of epidermal cyclic AMP is a beta-adrenergic adenylate cyclase-dependent process.

  1986cites this paper
• Determination of cyclic AMP and cyclic GMP in normal human epidermis and dermis.

  1985cites this paper
• [The importance of adrenergic receptors for dermatology].

  1985cites this paper
• [Undesirable skin reactions to lithium].

  1985cites this paper
• Activity of some lysosomal enzyme in rheumatoid and psoriatic arthritis

  1984cites this paper
• Immunological aspects of psoriasis. VI. Impairment of isoprenaline and theophylline‐induced inhibition of mitogen responsiveness

  1984cites this paper
• Mononuclear leukocyte cyclic adenosine monophosphate responses in psoriasis are normal.

  1984cites this paper
• Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis.

  1984cites this paper
• Chapter 19. Pharmacological Developments in Dermatology

  1983cites this paper
• Polyamines in psoriasis.

  1983cites this paper
• CULTURE OF UNINVOLVED AND INVOLVED PSORIATIC AND NORMAL EPIDERMIS WITH 3T3 FEEDER LAYERS

  1983cites this paper
• Effect of β‐adrenergic receptor blockade or refractoriness induced by isoproterenol on growth of keratinocytes in virto

  1982cites this paper
• Effect of beta-adrenergic receptor blockade or refractoriness induced by isoproterenol on growth of keratinocytes in vitro.

  1982cites this paper
• Commentary: Cyclic Adenosine Monophosphate Regulation of Normal and Psoriatic Epidermis

  1982cites this paper
• [Chalone(s) and epidermal growth factors].

  1982cites this paper
• The Role of Cyclic Nucleotides in Epithelium

  1982cites this paper
• Advances in genetics in dermatology.

  1982cites this paper
• Cyclic Nucleotides, Arachidonic Acid, and Polyamines in the Pathophysiology of Inflammatory Proliferative Skin Diseases

  1981cites this paper
• Enhanced monocyte and neutrophil cytotoxicity and normal cyclic nucleotide levels in severe psoriasis

  1981cites this paper
• Variations of cAMP in epidermis and plasma of male adult subjects.

  1981cites this paper
• Anomalies humorales au cours du psoriasis

  1980cites this paper
• Comparative studies of keratins isolated from psoriasis and atopic dermatitis.

  1980cites this paper
• Metabolic aspects of psoriasis: the basis for specific therapy.

  1980cites this paper
• The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis

  1980cites this paper
• Cyclic nucleotides and prostaglandins in psoriasis.

  1980cites this paper
• Immunological aspects of psoriasis

  1980cites this paper
• A cell culture model for the study of epidermal (chalone) homeostasis.

  1980cites this paper
• CYCLIC AMP LEVEL IN DIFFERENT LAYERS OF PSORIATIC EPIDERMIS

  1980cites this paper
• Interaction of Immune and Connective Tissue Cells

  1980cites this paper
• Cyclic nucleotides, prostaglandins and polyamines in psoriasis.

  1980cites this paper
• Epidermal cyclic AMP is not decreased in psoriasis lesions.

  1980cites this paper
• CYCLIC AMP AND EPIDERMAL CELL DIVISION

  1979cites this paper
• Regulatoren des epidermalen Zellzyklus

  1979cites this paper
• Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.

  1979cites this paper
• Ultrastructural study of mechanobullous desquamative gingivitis: a case report.

  1979cites this paper
• Ro 20-1724: an agent that significantly improves psoriatic lesions in double-blind clinical trials.

  1979cites this paper
• [Pathogenesis of psoriasis].

  1979cites this paper
• [HLA in psoriasis, population and family studies (author's transl)].

  1979cites this paper
• Cyclic nucleotide levels in psoriatic and normal keratomed epidermis.

  1979cites this paper
• [Role of cyclic nucleotides in the mechanism of epidermal cell proliferation].

  1979cites this paper
• Critical Molecular Variables in the Pathophysiology and Pharmacology of Psoriasis

  1979cites this paper
• Cyclic AMP and psoriasis once more.

  1979cites this paper
• Effects of local anesthesia on gingival cAMP levels.

  1979cites this paper
• Does ultraviolet-evoked prostaglandin formation protect skin from actinic cancer?

  1978cites this paper
• HLA C and D antigens associated with psoriasis

  1978cites this paper
• [The pathogenesis of psoriasis : realities and hypotheses (author's transl)].

  1978cites this paper
• Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.

  1978cites this paper
• Dermo-epidermale Erkrankungen

  1978cites this paper
• Determination of cyclic AMP in heat-separated human epidermal tissue.

  1978cites this paper
• NEW CONCEPTS IN THE PATHOGENESIS OF PSORIASIS

  1978cites this paper
• The relationship between cyclic adenosine 3′,5′‐monophosphate and biochemical events in rat skin after the induction of epidermal hyperplasia using hexadecane

  1978cites this paper
• Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and einephrine by the uninvolved and involved epidermis.

  1978cites this paper
• The effect of topical isoprenaline on psoriatic skin

  1978cites this paper
• [Pathogenesis of psoriasis in the light of current theories on the regulation of mitosis of epithelial cells].

  1978cites this paper
• REGULATION OF EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN PSORIASIS

  1978cites this paper
• Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents.

  1977cites this paper
• Effects of topical prostaglandin E analogue on normal hairless mouse epidermal DNA synthesis.

  1977cites this paper
• PHOSPHODIESTERAS E INHIBITORS AS POTENTIAL THERAPEUTIC AGENTS

  1977cites this paper
• Influence of psoralen on melatonin formation in rat pineal gland in organ culture.

  1977cites this paper